National Holdings Board of Directors


Michael S. Weiss was elected as Chairman of the Board of National Holdings Corporation on September 21, 2016. Mr. Weiss has served as Fortress Biotech's Executive Vice Chairman, Strategic Development since January 2014 and has served as co-vice chairman of Fortress Biotech's board of directors since December 2013. Since 2009, Mr. Weiss has served as Co-Portfolio Manager and Partner of Opus. In 2011, Mr. Weiss co-founded TG Therapeutics, Inc. (NASDAQ: TGTX), a publicly-traded biotechnology company focused on acquiring, developing and commercializing drugs for the treatment of b-cell malignancies. Mr. Weiss currently serves as TG’s Chairman, President and Chief Executive Officer. Prior to 2009, Mr. Weiss was Chairman and CEO of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) where he helped the company acquire and develop its lead drug Zerenex as well as executed a $100MM+ strategic alliance for Zerenex with JT Tobacco, Inc. and Torii Pharmaceutical Co., Ltd. Mr. Weiss began his professional career as a lawyer with Cravath, Swaine & Moore LLP in NYC. Mr. Weiss earned his J.D. from Columbia Law School and his B.S. in Finance from The University at Albany.

Robert Fagenson has been a member of National’s Board since March 2012. He served as Executive Co-Chairman from July 2012 to December 2014 and as Chairman from January 2014 to September 2016. Mr. Fagenson is currently the Vice Chairman of the Board. 

Mr. Fagenson spent the majority of his career at the New York Stock Exchange, where he was Managing Partner of one of largest specialist firms operating on the exchange trading floor. During his career as a member of the New York Stock Exchange beginning in 1973, Mr. Fagenson served as a Governor on the trading floor and was elected to the NYSE Board of Directors in 1993, where he served for six years, eventually becoming Vice Chairman of the Board in 1998 to 1999. He returned to the Board in 2003 and served until the Board was reconstituted with only non-industry directors in 2004. 

Mr. Fagenson  has been CEO of Fagenson & Co, Inc, a 50 year old broker dealer that engaged in institutional brokerage as well as investment banking and money management. On March 1, 2012, Fagenson transferred its brokerage operation, accounts and personnel to National Securities Corporation, and operates as a branch office of that firm. 

Mr. Fagenson has served on the boards of a number of public companies and presently is the Non-Executive Chairman of Document Security Systems, Inc. (NYSEMKT: DSS) and a member of the Board of Cash Technologies Corp. He is also a Director of the National Organization of Investment Professionals (NOIP). In addition to his business related activities, Mr. Fagenson, serves as Vice President and a Director of New York Services for the Handicapped, Treasurer and Director of the Centurion Foundation, Director of the Federal Law Enforcement Officers Association Foundation, Treasurer and Director of the New York City Police Museum and as a Member of the Board of the Sports and Arts in Schools Foundation. He is a Member of the alumni boards of both the Whitman School of Business and the Athletic Department at Syracuse University.. Mr. Fagenson received his B.S. degree in Transportation Sciences & Finance from Syracuse University in 1970.

Daniel Hume is currently a partner in Kirby McInerney, LLP's New York office and is a member of the firm's management committee. Mr. Hume's law practice focuses on securities, structured finance, and antitrust litigation and regulation. He joined Kirby McInerney, LLP in 1995. Since then, Mr. Hume has advised corporate, public, and individual clients, including some of the largest institutional investors in the world, and helped them recover billions of dollars in losses throughout the course of his career. His work has earned him assorted honors and recognition, including most recently being named to both the National Law Journal’s "hot" list and Law360’s "most feared" list for 2013. Mr. Hume is admitted to the New York State Bar and federal courts around the country, including the United States District Courts for the Southern and Eastern Districts of New York, the United States Court of Appeals for the Second, Third, Fourth, and Fifth Circuits, the Appellate Division of the Supreme Court of the State of New York, First Judicial Department, and the United States Supreme Court. He graduated from the State University of New York at Albany magna cum laude (B.A. Philosophy, 1988) and from Columbia Law School, where he served as Notes Editor for the Columbia Journal of Environmental Law (J.D., 1991).

Mr. Hume serves on the Board of Directors of TG Therapeutics Inc.

Neil Herskowitz has been the President at Riverside Claims LLC. since June 2004. Mr. Herskowitz has been the President of Riverside Contracting LLC since June 1998. He has been a Managing Member of ReGen Partners LLC since 1998 which includes ReGen Capital Investments LLC and Riverside Claims Investments LLC. Mr. Herskowitz serves as a Managing Member of Riverside Contracting LLC. In addition, he serves as Chairman of the Board of Directors of Starting Point Services for Children. Mr. Herskowitz also serves on the Board of Directors of Checkpoint Therapeutics, Inc. and Avenue Therapeutics, Inc. which are both affiliated companies of Fortress Biotech Inc. (FBIO). Previously, Mr. Herskowitz served on numerous boards of publicly traded companies including CB Pharma Acquisition Corp., CytRx Oncology Corporation, Alacrity Biosciences, Innovive Pharmaceuticals, TG Therapeutics, Inc. (formerly Manhattan Pharmaceuticals Inc.), and Chelsea Therapeutics International Ltd. (formerly Ivory Capital Corp.) Mr. Herskowitz holds a B.B.A. in Finance from Bernard M. Baruch College in 1978.

Eli Salig was President and Chief Operating Officer of ASI Solutions, Inc. (ASIS), a human resources consulting and outsourcing firm he co-founded in 1978. With prestigious clients such as Hewlett-Packard, Verizon and Morgan Stanley, and key acquisitions, ASIS grew to a major factor in the industry with over 1,600 employees world-wide and in excess of $100 million in annual revenue when it was acquired in 2001 by AON Consulting. Following the sale Mr. Salig was Executive Vice President of AON Consulting until 2004. Mr. Salig serves on the board of Robot Galaxy, a children's toy and experience company and is involved in local charitable activities. Mr. Salig began his professional career in the financial services industry serving in various Human Resources functions including recruitment & employment, compensation & benefits, and related regulatory & compliance areas. Mr. Salig is a graduate of Columbia College, and has  Master's Degrees from Columbia University and New York University Graduate School of Business.

Michael E. Singer most recently served as CEO and President of Ramius, a $13 billion (peak) alternative investment advisory platform.  As CEO of Ramius, Mr. Singer directed strategy and execution of the firm's business plan. Ramius partners with talented emerging alternative investment teams providing them seed and working capital, institutional infrastructure, proven sales and marketing and business guidance. During his tenure, he created a salesforce which raised more than $5 billion for the firm's investment teams and closed deals to onboard to the platform five talented hedge fund teams including Margate Capital. 

Mr. Singer was Co-President of Ivy Asset Management, a Fund of Hedge Funds business with over $15 billion in assets. At Ivy, Mr. Singer established the firm’s strategic plan and ran the day-to-day activities. He began his career at Weiss, Peck & Greer, a $17 billion asset management firm, where he spent nine years and served as Senior Managing Director and Executive Committee Member. He oversaw day-to-day operations, new product development, client relationship management, hedge fund sales and risk functions.

Mr. Singer received a Bachelor of Science degree in accounting with honors from Penn State University and a Juris Doctorate from the Emory University School of Law.  He is a frequent contributor to Bloomberg TV Market Makers and author of alternative industry white papers.